Listed

U S Physical Therapy Inc

USPHNYSECIK 885978HealthcareFiscal year ends Dec 31

Reports and events: 523 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

U S Physical Therapy Inc, Reports and events
FiledFormWhat it isAccession number
2024-11-0816:01 ET10-QQuarterly reportPeriod 2024-09-300001140361-24-045836
2024-11-0616:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-24-000062
2024-11-0116:05 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events0000885978-24-000059
2024-10-0716:07 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000056
2024-09-0316:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-24-000054
2024-08-2116:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000052
2024-08-1616:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000050
2024-08-1416:11 ET10-QQuarterly reportPeriod 2024-06-300001140361-24-037313
2024-08-1416:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-24-000048
2024-07-0314:44 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000045
2024-06-0516:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000043
2024-05-3116:05 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000885978-24-000041
2024-05-3016:07 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000036
2024-05-2116:19 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0000885978-24-000033
2024-05-0916:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000031
2024-05-0916:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000030
2024-05-0817:15 ET10-QQuarterly reportPeriod 2024-03-310001140361-24-024976
2024-05-0717:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-24-000026
2024-05-0613:38 ET8-K8.01 Other events0000885978-24-000024
2024-05-0216:06 ET8-K8.01 Other events0000885978-24-000022
2024-05-0116:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-24-000020
2024-04-1517:05 ETDEF 14AProxy statementPeriod 2024-05-210001140361-24-019890
2024-04-0216:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-24-000018
2024-03-1116:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-24-000015
2024-03-1117:41 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000013
2024-03-0716:12 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000885978-24-000011
2024-03-0116:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000007
2024-02-2916:35 ET10-KAnnual reportPeriod 2023-12-310001140361-24-010454
2024-02-2816:53 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000885978-24-000005
2024-01-0908:54 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-24-000002
2023-11-0916:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-23-000044
2023-11-0816:03 ET10-QQuarterly reportPeriod 2023-09-300001140361-23-052081
2023-11-0817:57 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000885978-23-000041
2023-11-0116:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-23-000039
2023-10-0217:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-23-000037
2023-08-2216:43 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-23-000034
2023-08-1616:40 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-23-000032
2023-08-0915:14 ET10-QQuarterly reportPeriod 2023-06-300001140361-23-038777
2023-08-0910:34 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000885978-23-000029
2023-08-0116:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-23-000026
2023-07-0708:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-23-000024
2023-05-3116:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000885978-23-000021
2023-05-3016:18 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000885978-23-000019
2023-05-2517:26 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-23-026687
2023-05-1717:23 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-23-025301
2023-05-1110:04 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-23-024033
2023-05-0516:16 ET8-K7.01 Regulation FD disclosure0000885978-23-000017
2023-05-0516:00 ET10-QQuarterly reportPeriod 2023-03-310001140361-23-023184
2023-05-0515:39 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000885978-23-000015
2023-04-1009:51 ETDEF 14AProxy statement0001140361-23-017433

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 13:45 ET. Listed shows no prices and gives no investment advice.